Today we have a small update from the Cellage team. The Cellage project is aiming to use synthetic biology to create a new way to detect the presence of harmful senescent cells as current methods are less than ideal and not as accurate as we need. Hi there, We have been quiet for a while…

For the first time in history, researchers have fused artificial cells with biological cells in a way that lets them work together. This opens the door for a variety of new possibilities and applications. Fusing biological and artificial cells The research team at Imperial College London uses a system that encapsulates biological cells within an…

A research team at MIT has used synthetic biology to create a gene circuit that triggers the immune system to attack cancer when it first detects the signs of the disease. The circuit works by only activating the immune response when two specific cancer biomarkers are detected. The new study was published in the journal…

A press release from the CellAge team. CellAge Limited (“CellAge”) has raised a seed round backed by Michael Greve´s Kizoo Technology Capital and a group of angel investors. CellAge, a privately held synthetic biology start-up aiming to develop tools and therapies for age-related diseases, has successfully completed a seed fundraising round. In this round Kizoo…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD